2. Peptides
  3. Peptide and Derivatives
  4. Labeled Peptides

Labeled Peptides

Custom Peptide Synthesis
 

Labeled Peptides (111):

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next
Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-114118F
    Semaglutide, FITC labeled
    Semaglutide, FITC labeled is a long-acting, selective, competitive, orally active GLP-1R agonist that can penetrate the blood-brain barrier. After activating GLP-1R, Semaglutide, FITC labeled promotes insulin secretion, inhibits gastric emptying and appetite, and at the same time enhances autophagy, inhibits oxidative stress and apoptosis. Semaglutide, FITC labeled also regulates mitochondrial function and lipid metabolism (such as reducing de novo lipogenesis in the liver). Semaglutide, FITC labeled has activities such as lowering blood sugar, reducing weight, neuroprotection (such as improving motor function in Parkinson's disease models, reducing α-synuclein aggregation) and improving hepatic steatosis. Semaglutide, FITC labeled can be used for the study of neurodegenerative diseases and liver diseases such as type 2 diabetes, obesity, Parkinson's disease, metabolic associated fatty liver disease (MASLD), and cancer.
    Semaglutide, FITC labeled
  • HY-P1264F
    α-Bungarotoxin, FITC labeled
    α-Bungarotoxin, FITC labeledis the FITC labelled α-Bungarotoxin (HY-P1264). α-Bungarotoxin is a competitive antagonist at nicotinic acetylcholine receptors (nAChRs).
    α-Bungarotoxin, FITC labeled
  • HY-P2535
    Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human 98.36%
    Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human is an C-terminal-labelled biotinylated GLP-1 (7-36) amide.
    Glucagon-Like Peptide 1 (GLP-1) (7-36)-Lys (Biotin), amide, human
  • HY-P2270
    Phalloidin-TRITC 915013-10-4
    Phalloidin-TRITC is a fluorescein derivative of Phalloidin, which can specifically label myof lin and display red fluorescence when labeled and can be observed using Tesred channels.
    Phalloidin-TRITC
  • HY-P1489F
    FAM-OVA (257-264) 99.87%
    FAM-OVA (257-264) is a biological active peptide. (FAM labeled HY-P1489)
    FAM-OVA (257-264)
  • HY-P5351A
    Hyaluronan-binding peptide, biotin labeled TFA
    Hyaluronan-binding peptide, biotin labeled TFA is a biological active peptide. (This peptide is a hyaluronan-binding peptide biotinylated through a C-terminal GGGSK linker. Hyaluronan (HA) is a nonsulfated glycosaminoglycan expressed in the extracellular matrix and on cell surfaces. HA plays a role in fertilization, embryonic development, wound healing, angiogenesis, leukocyte trafficking to inflamed tissues, and cancer metastasis. This peptide has been shown to block HA binding to CD44 receptors and inhibit T cell proliferation.).
    Hyaluronan-binding peptide, biotin labeled TFA
  • HY-P0201AF
    Substance P, FAM-labeled TFA 98.47%
    Substance P, FAM-labeled (TFA) is Substance P TFA (HY-P02101A) labeled with FAM fluorophore. Substance P TFA (Neurokinin P TFA) is a neuropeptide that acts as a neurotransmitter and neuromodulator in the central nervous system. The endogenous receptor of Substance P is neurokinin 1 receptor (NK1R).
    Substance P, FAM-labeled TFA
  • HY-P10674
    QMT-CBT
    QMT-CBT is a near-infrared aggregation-induced luminescent photon. After activation of caspase1 (Cas1), QMT-CBT undergoes a CBT-Cys click reaction to form a cyclic dimer QMT-Dimer (the first aggregate) and assembles into nanoparticles (the second aggregate), turning the AIE signal "on" to enhance imaging of Alzheimer's disease (AD).
    QMT-CBT
  • HY-P2550A
    β-Amyloid (1-40), FAM-labeled TFA 99.71%
    β-Amyloid (1-40), FAM-labeled TFA is a FAM fluorescently-labelled β-Amyloid (1-40) peptide (λex= 492 nm and λem= 518 nm).
    β-Amyloid (1-40), FAM-labeled TFA
  • HY-P1097F
    Biotin-Gastrin-1, human (1-17) 663625-43-2 99.02%
    Biotin-Gastrin-1, human (1-17) is a biological active peptide. (Biotin-labeled HY-P1097)
    Biotin-Gastrin-1, human (1-17)
  • HY-P0286F
    Biotin-OVA (323-339) 99.51%
    Biotin-OVA (323-339) is a biological active peptide. (Biotin labeled HY-P0286)
    Biotin-OVA (323-339)
  • HY-P2546
    Biotin-Substance P 87468-58-4 99.91%
    Biotin-Substance P is the biotin tagged Substance P. Substance P (Neurokinin P) is a neuropeptide, acting as a neurotransmitter and as a neuromodulator in the CNS. The endogenous receptor for substance P is neurokinin 1 receptor (NK1-receptor, NK1R).
    Biotin-Substance P
  • HY-P4154
    Bevonescein 2276787-79-0 99.97%
    Bevonescein (ALM-488) is a novel, intravenously-administrated fluorescein-conjugated peptide that binds nerve-associated connective tissue, labels peripheral nerves under real-time fluorescence imaging (FL) in living mice and human ex vivo nerve tissue. Bevonescein is a peptide-linked tracer which fluorescently labeled both intact and degenerated nerves.
    Bevonescein
  • HY-P2609F
    PACAP (1-38), amide, Biotin-labeled 98.92%
    PACAP (1-38), amide, Biotin-labeled is a biological active peptide. (Biotin-labeled HY-P0221)
    PACAP (1-38), amide, Biotin-labeled
  • HY-P0286F1A
    FITC-OVA (323-339) TFA
    FITC-OVA (323-339) TFA is a biological active peptide. (FITC labeled HY-P0286)
    FITC-OVA (323-339) TFA
  • HY-13948F
    Biotin-Ahx-Angiotensin II human 115102-72-2 99.96%
    Biotin-Ahx-Angiotensin II human (Biotin-Ahx-Angiotensin II; Biotin-Ahx-Ang II; Biotin-Ahx-DRVYIHPF) is a biological active peptide. (biotin labeled HY-13948)
    Biotin-Ahx-Angiotensin II human
  • HY-P2500
    (Arg)9, FAM-labeled 99.83%
    (Arg)9, FAM-labeled, a cell-penetrating peptide (CPP), is a nona-arginine (ARG) with FAM label. CPPs have emerged as powerful tools for delivering bioactive cargoes into the cytosol of intact cells.
    (Arg)9, FAM-labeled
  • HY-13948F1
    Angiotensin II human, FAM-labeled 99.53%
    Angiotensin II human, FAM-labeled (Angiotensin II, FAM-labeled ; Ang II, FAM-labeled ; DRVYIHPF, FAM-labeled) is a biological active peptide. (FAM labeled HY-13948)
    Angiotensin II human, FAM-labeled
  • HY-P2292
    Omiganan, FITC labeled 98.29%
    Omiganan, FITC labeled is a peptide-FITC complex composed of Omiganan and a FITC. Omiganan is a bactericidal and fungicidal cationic peptide being developed as a topical gel for prevention of catheter-associated infections. FITC is a derivative of fluorescein for the labeling of amines.
    Omiganan, FITC labeled
  • HY-P1755F
    p53 (17-26), FITC labeled 98.31%
    p53 (17-26), FITC labeled is a biological active peptide.
    p53 (17-26), FITC labeled
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next